Abstract:Objective To investigate the expression of TFAR19 protein in epithelial ovarian cancer.Methods Expression of TFAR19 protein in 79 cases of epithelial ovarian cancer (including 33 cases of serious adenocarcinoma, 13 cases of mucinous adenocarcinoma, 11 cases of endometroid adenocarcinoma, 22 cases of other pathological type), 33 cases of benign ovarian neoplasma (including 18 cases of serious adenoplasma, 13 cases of mucinous adenoplasma, 2 cases of other benign neo-plasma), and 11 cases of normal ovarian tissues were detected by immunohistochemical technique, the percentages of positive cells and their expression intensity of TFAR19 protein were investigated. Results The percentage of strong positive cells in epithelial ovarian carcinoma (39.24%) is significant lower than that of nomal ovarian epithelium (81.82%) and benign tumors (75.76% ), (P 0.05) .The different expression of TFAR19 is associated with histological classification , FIGO staging and histological grading. The percentage of strong positive cells of different FIGO staging is FIGO I 80%, FIGO II 45.45%, FIGO III 31.25%, FIGO IV 30%; of different histological grading is G1: 62.5%, G2: 50%, G3: 29.79%; The percentage of strong positive cells in malignant mucinous tumors is higher than that of malignant serous and endometroid tumors.Conclusions The expression of TFAR19 protein is varied with histological classification of epithelial ovarian cancer and were downregulated with increasing of clinical staging and histological grading. It suggests that TFAR19 is a important aopotosis regulate factors in epithelial ovarian cancer.

Expression of TFAR19 Protein in Epithelial Ovarian Cancer